Health & Science

“Inherent Conflict of Interest:” Cannabiz Slams DEA MED Proposal

By Hilary Corrigan
May 12, 2020
story-image
(Photo by Eric Kayne/Getty Images)
Two influential cannabis advocacy groups say the federal government’s proposed rules to accelerate MED research would give too much control to U.S. Drug Enforcement Administration (DEA).The National Cannabis Industry Association opposed the entire rulemaking, warning on May 11 that it...

This content is FREE for registered users.

To view this content you need to register as a Weedweek member.

If you are already a member please login below.